Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease

CompletedOBSERVATIONAL

Enrollment

166

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

October 31, 2020

Conditions

Parkinson DiseaseMultiple System AtrophyREM Sleep Behavior DisorderPure Autonomic FailureDementia With Lewy Bodies

Trial Locations (1)

New York University School of Medicine, New York

All Listed Sponsors

collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

NYU Langone Health

OTHER

NCT02640339 - Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson Disease | Biotech Hunter | Biotech Hunter